Featured ViaLase technology could impact glaucoma care for patients worldwide

Published on May 1st, 2022 📆 | 5339 Views ⚑

0

ViaLase technology could impact glaucoma care for patients worldwide


iSpeech

OPT-302 combination therapy with ranibizumab shows BCVA, anatomic improvements in patients with PCV

Riad Sherif, CEO of Oculis, gives a company update on clinical trials, financing and other items in the pipeline





Study: Surgeon and anesthesiologist satisfaction an unreliable indicator of patient satisfaction during ocular surgery

Source link

Tagged with:



Comments are closed.